Which are the causes of Chronic myelogenous leukemia (CML)?

Chronic myelogenous leukemia (CML) is primarily caused by a somatic genetic mutation known as the Philadelphia chromosome, which creates the BCR-ABL1 fusion gene. Unlike many other cancers, this condition is not hereditary; it arises from a spontaneous, acquired chromosomal translocation in a single bone marrow stem cell during a person's lifetime.

What is the primary cause of Chronic myelogenous leukemia?

The hallmark of Chronic myelogenous leukemia (CML) is the Philadelphia chromosome, a specific genetic abnormality where pieces of chromosome 9 and chromosome 22 swap places. This translocation creates the BCR-ABL1 fusion gene, which acts like a "stuck accelerator" in a car, forcing the body to produce an uncontrolled number of abnormal white blood cells. This is a somatic mutation, meaning it happens in the blood-forming cells and cannot be passed down to children.

Is Chronic myelogenous leukemia hereditary?

No, Chronic myelogenous leukemia (CML) is not an inherited disease. You cannot pass the Philadelphia chromosome to your offspring. Because the genetic damage occurs in the hematopoietic (blood-forming) stem cells after birth, it is considered an acquired condition rather than a congenital or familial one.

Are there known environmental risk factors for CML?

While the exact trigger for the initial chromosomal swap remains largely unknown, research has identified a few potential influences. Current understanding of Chronic myelogenous leukemia (CML) suggests the following factors:

• Ionizing Radiation: High-dose radiation exposure is the only well-established environmental risk factor, though it accounts for a very small percentage of cases.


• Advanced Age: The risk of developing Chronic myelogenous leukemia (CML) increases with age, with a median age of diagnosis around 64 years.


• Gender: Data indicates a slightly higher incidence of Chronic myelogenous leukemia (CML) in males compared to females.

How does current research approach the etiology of the disease?

Current research is focused on why this specific translocation occurs in some individuals and not others. While we understand the molecular mechanism of the BCR-ABL1 protein, scientists are investigating whether subtle immune system dysfunctions or chronic inflammatory states might create an environment that favors the survival of these mutated cells. With 287 members in the DiseaseMaps.org community, we continue to track patient experiences to better understand the long-term impact of living with this condition.

Next steps

• Consult a hematologist-oncologist to discuss your specific genetic profile and treatment options.


• Join the DiseaseMaps.org community to connect with others currently navigating Chronic myelogenous leukemia (CML).


• Stay informed about clinical trials investigating next-generation tyrosine kinase inhibitors (TKIs).

Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Chronic Myelogenous Leukemia.


• Orphanet: Chronic Myeloid Leukemia (ORPHA:527).


• American Cancer Society: What Causes Chronic Myeloid Leukemia?


• OMIM (Online Mendelian Inheritance in Man): Entry #608232 (BCR-ABL1).